TNF and interstitial lung disease: We observed that DEGs upregulated in patients with ASS-ILD were involved in processes including responses to type I and II interferons, cellular response to interleukin-1, cellular response to tumor necrosis factor, and NF-kappaB signaling using GO analysis (Figure 6A).